Association of Single Nucleotide Polymorphisms in the Cyclooxygenase-2 (COX-2) Gene with Periodontal Disease-A Systematic Review with Meta-Analysis and Implications for Personalized Dentistry.

IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Vasiliki Savva, Ioannis Fragkioudakis, Dimitra Sakellari
{"title":"Association of Single Nucleotide Polymorphisms in the Cyclooxygenase-2 (COX-2) Gene with Periodontal Disease-A Systematic Review with Meta-Analysis and Implications for Personalized Dentistry.","authors":"Vasiliki Savva, Ioannis Fragkioudakis, Dimitra Sakellari","doi":"10.3390/jpm15080351","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Genetic polymorphisms in the cyclooxygenase-2 (COX-2) gene may contribute to individual susceptibility to periodontal disease. A meta-analysis assessed the association between three COX-2 single-nucleotide polymorphisms (SNPs) namely, -765 G/C (rs20417), -1195 G/A (rs689466), and 8473 T/C (rs5275), and the risk of CP. <b>Methods:</b> Following the PRISMA 2020 guidelines, we conducted a comprehensive search of five electronic databases and additional sources. The eligible studies were observational (case-control or cohort) with genotypic data comparing individuals with periodontal disease and periodontally healthy controls. Methodological quality was assessed using the Newcastle-Ottawa Scale (NOS), and the certainty of evidence was evaluated via the GRADE framework. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated under dominant genetic models. <b>Results:</b> Seven studies (n = 1467 participants) met the inclusion criteria. No eligible studies evaluated the 8473 T/C SNP. The meta-analysis of the -765 G/C variant revealed a significant association with periodontal disease (OR = 1.61; 95% CI: 1.12-2.32, <i>p</i> = 0.03; I<sup>2</sup> = 0%). For the -1195 G/A variant, the pooled OR was 1.86 (95% CI: 1.00-3.43, <i>p</i> = 0.05; I<sup>2</sup> = 35%), suggesting a borderline significant association. The certainty of evidence was graded as moderate for -765 G/C and low for -1195 G/A. <b>Conclusions:</b> The COX-2 -765 G/C polymorphism is significantly associated with increased CP risk, while the -1195 G/A variant shows a potential, though less certain, link. Larger, high-quality studies using standardized classifications are needed to confirm these associations.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"15 8","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12387893/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jpm15080351","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Genetic polymorphisms in the cyclooxygenase-2 (COX-2) gene may contribute to individual susceptibility to periodontal disease. A meta-analysis assessed the association between three COX-2 single-nucleotide polymorphisms (SNPs) namely, -765 G/C (rs20417), -1195 G/A (rs689466), and 8473 T/C (rs5275), and the risk of CP. Methods: Following the PRISMA 2020 guidelines, we conducted a comprehensive search of five electronic databases and additional sources. The eligible studies were observational (case-control or cohort) with genotypic data comparing individuals with periodontal disease and periodontally healthy controls. Methodological quality was assessed using the Newcastle-Ottawa Scale (NOS), and the certainty of evidence was evaluated via the GRADE framework. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated under dominant genetic models. Results: Seven studies (n = 1467 participants) met the inclusion criteria. No eligible studies evaluated the 8473 T/C SNP. The meta-analysis of the -765 G/C variant revealed a significant association with periodontal disease (OR = 1.61; 95% CI: 1.12-2.32, p = 0.03; I2 = 0%). For the -1195 G/A variant, the pooled OR was 1.86 (95% CI: 1.00-3.43, p = 0.05; I2 = 35%), suggesting a borderline significant association. The certainty of evidence was graded as moderate for -765 G/C and low for -1195 G/A. Conclusions: The COX-2 -765 G/C polymorphism is significantly associated with increased CP risk, while the -1195 G/A variant shows a potential, though less certain, link. Larger, high-quality studies using standardized classifications are needed to confirm these associations.

Abstract Image

Abstract Image

Abstract Image

环氧化酶-2 (COX-2)基因单核苷酸多态性与牙周病的关系——荟萃分析的系统综述及其对个性化牙科的影响
背景:环氧化酶-2 (COX-2)基因的遗传多态性可能与个体对牙周病的易感性有关。荟萃分析评估了3个COX-2单核苷酸多态性(snp),即-765 G/C (rs20417)、-1195 G/A (rs689466)和8473 T/C (rss5275)与CP风险之间的关系。方法:根据PRISMA 2020指南,我们对5个电子数据库和其他来源进行了全面检索。符合条件的研究是观察性的(病例对照或队列),具有比较牙周病患者和牙周健康对照者的基因型数据。使用纽卡斯尔-渥太华量表(NOS)评估方法学质量,并通过GRADE框架评估证据的确定性。在显性遗传模型下计算合并优势比(ORs)和95%置信区间(CIs)。结果:7项研究(n = 1467名受试者)符合纳入标准。没有符合条件的研究评估8473 T/C SNP。荟萃分析显示-765 G/C变异与牙周病有显著相关性(OR = 1.61; 95% CI: 1.12-2.32, p = 0.03; I2 = 0%)。对于-1195 G/A变异,合并OR为1.86 (95% CI: 1.00-3.43, p = 0.05; I2 = 35%),表明存在临界显著相关性。证据的确定性等级为-765 G/C为中等,-1195 G/A为低。结论:COX-2 -765 G/C多态性与CP风险增加显著相关,而-1195 G/A变异显示出潜在的联系,尽管不太确定。需要使用标准化分类进行更大规模、高质量的研究来证实这些关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Personalized Medicine
Journal of Personalized Medicine Medicine-Medicine (miscellaneous)
CiteScore
4.10
自引率
0.00%
发文量
1878
审稿时长
11 weeks
期刊介绍: Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信